

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | hemidesmosome assembly (GO:0031581) | 7.89642004 |
| 2 | bile acid and bile salt transport (GO:0015721) | 6.34670759 |
| 3 | regulation of water loss via skin (GO:0033561) | 6.01491208 |
| 4 | establishment of skin barrier (GO:0061436) | 5.95708968 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 5.89469796 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.87562064 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.87562064 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.74139820 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 5.74139820 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 5.31216142 |
| 11 | multicellular organismal water homeostasis (GO:0050891) | 5.15686446 |
| 12 | cysteine metabolic process (GO:0006534) | 5.01152188 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.00819830 |
| 14 | tryptophan catabolic process (GO:0006569) | 4.87118729 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.87118729 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.87118729 |
| 17 | keratinocyte proliferation (GO:0043616) | 4.82581988 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.79163249 |
| 19 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.60581737 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.57156067 |
| 21 | tryptophan metabolic process (GO:0006568) | 4.52469674 |
| 22 | urea cycle (GO:0000050) | 4.43267662 |
| 23 | urea metabolic process (GO:0019627) | 4.43267662 |
| 24 | cellular glucuronidation (GO:0052695) | 4.38924382 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 4.37141624 |
| 26 | homocysteine metabolic process (GO:0050667) | 4.34666143 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 4.33072434 |
| 28 | NADH metabolic process (GO:0006734) | 4.30262055 |
| 29 | bile acid biosynthetic process (GO:0006699) | 4.28718336 |
| 30 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.25309040 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 4.20534752 |
| 32 | water homeostasis (GO:0030104) | 4.18635654 |
| 33 | positive regulation of pseudopodium assembly (GO:0031274) | 4.18471238 |
| 34 | keratinization (GO:0031424) | 4.18300667 |
| 35 | complement activation, alternative pathway (GO:0006957) | 4.16682833 |
| 36 | GDP-mannose metabolic process (GO:0019673) | 4.15415618 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.14298799 |
| 38 | ethanol oxidation (GO:0006069) | 4.13740137 |
| 39 | negative regulation of sterol transport (GO:0032372) | 4.10174653 |
| 40 | negative regulation of cholesterol transport (GO:0032375) | 4.10174653 |
| 41 | bile acid metabolic process (GO:0008206) | 4.08586634 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.04678201 |
| 43 | phospholipid efflux (GO:0033700) | 4.04090669 |
| 44 | drug transmembrane transport (GO:0006855) | 4.03952764 |
| 45 | positive regulation of epidermal cell differentiation (GO:0045606) | 4.03794374 |
| 46 | angiotensin maturation (GO:0002003) | 4.02483663 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.00207290 |
| 48 | drug catabolic process (GO:0042737) | 4.00134799 |
| 49 | gap junction assembly (GO:0016264) | 3.99801886 |
| 50 | flavonoid metabolic process (GO:0009812) | 3.96486250 |
| 51 | uronic acid metabolic process (GO:0006063) | 3.95839191 |
| 52 | glucuronate metabolic process (GO:0019585) | 3.95839191 |
| 53 | regulation of protein activation cascade (GO:2000257) | 3.95763574 |
| 54 | regulation of cholesterol homeostasis (GO:2000188) | 3.94369740 |
| 55 | regulation of cholesterol esterification (GO:0010872) | 3.94257867 |
| 56 | epoxygenase P450 pathway (GO:0019373) | 3.93513168 |
| 57 | epithelial cell-cell adhesion (GO:0090136) | 3.93032261 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.91326401 |
| 59 | acylglycerol homeostasis (GO:0055090) | 3.91326401 |
| 60 | alpha-linolenic acid metabolic process (GO:0036109) | 3.90245274 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.90186927 |
| 62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.88896061 |
| 63 | protein-lipid complex remodeling (GO:0034368) | 3.88896061 |
| 64 | macromolecular complex remodeling (GO:0034367) | 3.88896061 |
| 65 | protein carboxylation (GO:0018214) | 3.88640626 |
| 66 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.88640626 |
| 67 | intestinal cholesterol absorption (GO:0030299) | 3.86942805 |
| 68 | negative regulation of fibrinolysis (GO:0051918) | 3.86342202 |
| 69 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.84754684 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.81718808 |
| 71 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.80374609 |
| 72 | lysine metabolic process (GO:0006553) | 3.78948632 |
| 73 | lysine catabolic process (GO:0006554) | 3.78948632 |
| 74 | phospholipid homeostasis (GO:0055091) | 3.78357862 |
| 75 | regulation of complement activation (GO:0030449) | 3.74445961 |
| 76 | cellular ketone body metabolic process (GO:0046950) | 3.72866673 |
| 77 | regulation of fibrinolysis (GO:0051917) | 3.69726487 |
| 78 | ethanol metabolic process (GO:0006067) | 3.66816135 |
| 79 | regulation of pseudopodium assembly (GO:0031272) | 3.66489842 |
| 80 | intestinal absorption (GO:0050892) | 3.65252589 |
| 81 | primary alcohol catabolic process (GO:0034310) | 3.64740366 |
| 82 | regulation of bile acid biosynthetic process (GO:0070857) | 3.63198388 |
| 83 | Golgi transport vesicle coating (GO:0048200) | 3.62427275 |
| 84 | COPI coating of Golgi vesicle (GO:0048205) | 3.62427275 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 3.62013441 |
| 86 | alkaloid metabolic process (GO:0009820) | 3.61271462 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.61093356 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.61093356 |
| 89 | cholesterol homeostasis (GO:0042632) | 3.58817309 |
| 90 | intestinal epithelial cell development (GO:0060576) | 3.58053455 |
| 91 | activation of Rac GTPase activity (GO:0032863) | 3.55941923 |
| 92 | alpha-amino acid catabolic process (GO:1901606) | 3.55821556 |
| 93 | sterol homeostasis (GO:0055092) | 3.54807044 |
| 94 | regulation of keratinocyte proliferation (GO:0010837) | 3.53641780 |
| 95 | acute-phase response (GO:0006953) | 3.52998054 |
| 96 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.51162676 |
| 97 | exogenous drug catabolic process (GO:0042738) | 3.49671752 |
| 98 | cell-substrate junction assembly (GO:0007044) | 3.48144401 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.47487930 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.46786995 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 3.46226033 |
| 102 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.45941212 |
| 103 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.45501315 |
| 104 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.45501315 |
| 105 | regulation of cholesterol metabolic process (GO:0090181) | 3.45067411 |
| 106 | regulation of guanylate cyclase activity (GO:0031282) | 3.44390362 |
| 107 | tyrosine metabolic process (GO:0006570) | 3.43988245 |
| 108 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.39835006 |
| 109 | carnitine metabolic process (GO:0009437) | 3.39606225 |
| 110 | drug transport (GO:0015893) | 3.38878387 |
| 111 | indolalkylamine metabolic process (GO:0006586) | 3.38345481 |
| 112 | citrulline biosynthetic process (GO:0019240) | 3.38096485 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 3.37481948 |
| 114 | renal system process involved in regulation of blood volume (GO:0001977) | 3.37391914 |
| 115 | glutamate metabolic process (GO:0006536) | 3.33046536 |
| 116 | proline biosynthetic process (GO:0006561) | 3.31443292 |
| 117 | plasma lipoprotein particle assembly (GO:0034377) | 3.30085053 |
| 118 | positive regulation of epidermis development (GO:0045684) | 3.29637546 |
| 119 | cholesterol efflux (GO:0033344) | 3.27856735 |
| 120 | response to nitrosative stress (GO:0051409) | 3.27279840 |
| 121 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.25656145 |
| 122 | fatty acid oxidation (GO:0019395) | 3.24370465 |
| 123 | urate metabolic process (GO:0046415) | 3.24206978 |
| 124 | amine catabolic process (GO:0009310) | 3.23791429 |
| 125 | cellular biogenic amine catabolic process (GO:0042402) | 3.23791429 |
| 126 | drug metabolic process (GO:0017144) | 3.22634391 |
| 127 | arginine metabolic process (GO:0006525) | 3.22526682 |
| 128 | plasma lipoprotein particle clearance (GO:0034381) | 3.20958385 |
| 129 | ketone body metabolic process (GO:1902224) | 3.20268302 |
| 130 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.19578917 |
| 131 | proline metabolic process (GO:0006560) | 3.19170337 |
| 132 | lipoprotein metabolic process (GO:0042157) | 3.18802738 |
| 133 | tight junction assembly (GO:0070830) | 3.18641739 |
| 134 | serine family amino acid biosynthetic process (GO:0009070) | 3.16813254 |
| 135 | lipid oxidation (GO:0034440) | 3.16746414 |
| 136 | keratinocyte differentiation (GO:0030216) | 3.13264079 |
| 137 | regulation of keratinocyte differentiation (GO:0045616) | 3.08455947 |
| 138 | protein autoprocessing (GO:0016540) | 3.06355910 |
| 139 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.05367537 |
| 140 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.00957268 |
| 141 | citrulline metabolic process (GO:0000052) | 2.97874348 |
| 142 | intermediate filament organization (GO:0045109) | 2.94106620 |
| 143 | epidermal cell differentiation (GO:0009913) | 2.91535288 |
| 144 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.88838700 |
| 145 | regulation of viral release from host cell (GO:1902186) | 2.87910879 |
| 146 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.86005370 |
| 147 | negative regulation of cell fate specification (GO:0009996) | 2.82768387 |
| 148 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.81367453 |
| 149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.81245651 |
| 150 | regulation of vitamin metabolic process (GO:0030656) | 2.80780663 |
| 151 | epidermis development (GO:0008544) | 2.78254746 |
| 152 | keratinocyte development (GO:0003334) | 2.78073267 |
| 153 | renal filtration (GO:0097205) | 2.76335304 |
| 154 | cell-cell junction assembly (GO:0007043) | 2.74344977 |
| 155 | fructose metabolic process (GO:0006000) | 2.73404458 |
| 156 | regulation of epidermal cell differentiation (GO:0045604) | 2.73204788 |
| 157 | O-glycan processing (GO:0016266) | 2.72488626 |
| 158 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.71092217 |
| 159 | endocrine process (GO:0050886) | 2.71092217 |
| 160 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.71092217 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.69524969 |
| 162 | phenylpropanoid metabolic process (GO:0009698) | 2.69161381 |
| 163 | positive regulation of respiratory burst (GO:0060267) | 2.66724219 |
| 164 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.66456310 |
| 165 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.66113746 |
| 166 | antimicrobial humoral response (GO:0019730) | 2.64738878 |
| 167 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.64141910 |
| 168 | regulation of epidermis development (GO:0045682) | 2.63754773 |
| 169 | surfactant homeostasis (GO:0043129) | 2.63633446 |
| 170 | sphingomyelin metabolic process (GO:0006684) | 2.63455331 |
| 171 | protein retention in ER lumen (GO:0006621) | 2.63440859 |
| 172 | regulation of systemic arterial blood pressure (GO:0003073) | 2.62400331 |
| 173 | regulation of metalloenzyme activity (GO:0048552) | 2.61538619 |
| 174 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.58904866 |
| 175 | regulation of respiratory burst (GO:0060263) | 2.58863910 |
| 176 | negative regulation of epidermis development (GO:0045683) | 2.58403718 |
| 177 | diterpenoid biosynthetic process (GO:0016102) | 2.57230577 |
| 178 | atrioventricular valve morphogenesis (GO:0003181) | 2.56662657 |
| 179 | glutathione biosynthetic process (GO:0006750) | 2.52918362 |
| 180 | vitamin transmembrane transport (GO:0035461) | 2.52596567 |
| 181 | auditory receptor cell differentiation (GO:0042491) | 2.52504374 |
| 182 | prostaglandin metabolic process (GO:0006693) | 2.50317722 |
| 183 | prostanoid metabolic process (GO:0006692) | 2.50317722 |
| 184 | desmosome organization (GO:0002934) | 10.1977474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.89406324 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21665037 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.74485077 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.73236036 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.00907975 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84211561 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.33824883 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.59034105 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44387633 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.39987219 |
| 11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.09726526 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.46199985 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.43197367 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.40067145 |
| 15 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.25214220 |
| 16 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04343149 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.97301851 |
| 18 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.85905365 |
| 19 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.79040998 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77087631 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.73662321 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71638761 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67848642 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.64031134 |
| 25 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.62003657 |
| 26 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61694995 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58564801 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.58510655 |
| 29 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.57857796 |
| 30 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56085535 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51673439 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49611672 |
| 33 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.49446155 |
| 34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45854452 |
| 35 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.45572075 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.40927923 |
| 37 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33767269 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33384669 |
| 39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31313806 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29359259 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29322717 |
| 42 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27638484 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27459152 |
| 44 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.26308061 |
| 45 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25731347 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.24681416 |
| 47 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23480965 |
| 48 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21972972 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21871830 |
| 50 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21336024 |
| 51 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.21175724 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21128118 |
| 53 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20136042 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19797644 |
| 55 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.15280226 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14537922 |
| 57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.14346096 |
| 58 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.13300962 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13119359 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12871881 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11979252 |
| 62 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.11126163 |
| 63 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11052070 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08085930 |
| 65 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07214921 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07157770 |
| 67 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06950948 |
| 68 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04590490 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04158035 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04030758 |
| 71 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03874876 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.03419717 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03042318 |
| 74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02983414 |
| 75 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02249549 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02057909 |
| 77 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01324228 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01113684 |
| 79 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.00352577 |
| 80 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99969508 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.98888174 |
| 82 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97962743 |
| 83 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97736125 |
| 84 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97496486 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97220481 |
| 86 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97177722 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.97096217 |
| 88 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97017766 |
| 89 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.96871406 |
| 90 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96834494 |
| 91 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.95583425 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.95214721 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94494947 |
| 94 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91390415 |
| 95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90905466 |
| 96 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90742376 |
| 97 | KDM2B_26808549_Chip-Seq_K562_Human | 0.90230450 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.90041115 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.88893885 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88322519 |
| 101 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.85606648 |
| 102 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84204194 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83781170 |
| 104 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82134231 |
| 105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81701913 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80903403 |
| 107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80086703 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.79949257 |
| 109 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79657657 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78474043 |
| 111 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77263933 |
| 112 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77143859 |
| 113 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76860972 |
| 114 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.76684095 |
| 115 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76122342 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.76064381 |
| 117 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75345112 |
| 118 | GATA1_22025678_ChIP-Seq_K562_Human | 0.75331912 |
| 119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74677879 |
| 120 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73408774 |
| 121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73408774 |
| 122 | VDR_22108803_ChIP-Seq_LS180_Human | 0.73338298 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.68189740 |
| 124 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67450209 |
| 125 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.67209485 |
| 126 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.66787682 |
| 127 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.66587196 |
| 128 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.66257702 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65042934 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.64470061 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63458867 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63058926 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.63046818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.41137367 |
| 2 | MP0005360_urolithiasis | 6.30185530 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 6.01916703 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.12276187 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.63719440 |
| 6 | MP0005365_abnormal_bile_salt | 4.39921140 |
| 7 | MP0003252_abnormal_bile_duct | 3.56043616 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.39703962 |
| 9 | MP0000566_synostosis | 3.31683439 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.18902326 |
| 11 | MP0004019_abnormal_vitamin_homeostasis | 2.97908773 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.70092331 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.53379047 |
| 14 | MP0003283_abnormal_digestive_organ | 2.52098892 |
| 15 | MP0009840_abnormal_foam_cell | 2.43952468 |
| 16 | MP0003195_calcinosis | 2.34063689 |
| 17 | MP0009379_abnormal_foot_pigmentation | 2.28920406 |
| 18 | MP0005409_darkened_coat_color | 2.26373383 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.25741262 |
| 20 | MP0003941_abnormal_skin_development | 2.22589806 |
| 21 | MP0005332_abnormal_amino_acid | 2.19755172 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.19332887 |
| 23 | MP0005083_abnormal_biliary_tract | 2.04425608 |
| 24 | MP0004264_abnormal_extraembryonic_tissu | 2.03024680 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 2.02198674 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.79204758 |
| 27 | MP0009053_abnormal_anal_canal | 1.67590109 |
| 28 | MP0002796_impaired_skin_barrier | 1.67295593 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.66095394 |
| 30 | MP0010771_integument_phenotype | 1.63932371 |
| 31 | MP0002822_catalepsy | 1.62752918 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.58519026 |
| 33 | MP0005451_abnormal_body_composition | 1.56504401 |
| 34 | MP0005023_abnormal_wound_healing | 1.56124633 |
| 35 | MP0000609_abnormal_liver_physiology | 1.54821993 |
| 36 | MP0003868_abnormal_feces_composition | 1.53280115 |
| 37 | MP0000462_abnormal_digestive_system | 1.43972756 |
| 38 | MP0005275_abnormal_skin_tensile | 1.42446990 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.40262700 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.37940396 |
| 41 | MP0002254_reproductive_system_inflammat | 1.32933923 |
| 42 | MP0010678_abnormal_skin_adnexa | 1.32526377 |
| 43 | MP0003878_abnormal_ear_physiology | 1.32523552 |
| 44 | MP0005377_hearing/vestibular/ear_phenot | 1.32523552 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.31738271 |
| 46 | MP0004381_abnormal_hair_follicle | 1.30302538 |
| 47 | MP0000490_abnormal_crypts_of | 1.26576605 |
| 48 | MP0004858_abnormal_nervous_system | 1.25162779 |
| 49 | MP0002098_abnormal_vibrissa_morphology | 1.23694676 |
| 50 | MP0001756_abnormal_urination | 1.21950237 |
| 51 | MP0008260_abnormal_autophagy | 1.17348015 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14379771 |
| 53 | MP0004043_abnormal_pH_regulation | 1.13317072 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.11192930 |
| 55 | MP0003693_abnormal_embryo_hatching | 1.04872211 |
| 56 | MP0004272_abnormal_basement_membrane | 1.03272431 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.03194345 |
| 58 | MP0001764_abnormal_homeostasis | 1.03139241 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 1.01703869 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.01658816 |
| 61 | MP0001765_abnormal_ion_homeostasis | 1.00550243 |
| 62 | MP0002234_abnormal_pharynx_morphology | 1.00251069 |
| 63 | MP0000627_abnormal_mammary_gland | 0.97242674 |
| 64 | MP0003866_abnormal_defecation | 0.97229026 |
| 65 | MP0005076_abnormal_cell_differentiation | 0.95500216 |
| 66 | MP0005501_abnormal_skin_physiology | 0.93966529 |
| 67 | MP0003186_abnormal_redox_activity | 0.91072998 |
| 68 | MP0005058_abnormal_lysosome_morphology | 0.88701386 |
| 69 | MP0000477_abnormal_intestine_morphology | 0.88222646 |
| 70 | MP0000858_altered_metastatic_potential | 0.87497243 |
| 71 | MP0004782_abnormal_surfactant_physiolog | 0.87157055 |
| 72 | MP0001216_abnormal_epidermal_layer | 0.86165737 |
| 73 | MP0004947_skin_inflammation | 0.83491658 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.82873964 |
| 75 | MP0000598_abnormal_liver_morphology | 0.82677147 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.81947969 |
| 77 | MP0000003_abnormal_adipose_tissue | 0.81003521 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.80692637 |
| 79 | MP0000367_abnormal_coat/_hair | 0.78804660 |
| 80 | MP0005381_digestive/alimentary_phenotyp | 0.78550751 |
| 81 | MP0005375_adipose_tissue_phenotype | 0.78090092 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.75859343 |
| 83 | MP0000377_abnormal_hair_follicle | 0.75282440 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.75151912 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 0.73692184 |
| 86 | MP0000604_amyloidosis | 0.72792134 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.72626476 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.71892345 |
| 89 | MP0009642_abnormal_blood_homeostasis | 0.71501123 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.70625516 |
| 91 | MP0001663_abnormal_digestive_system | 0.70406500 |
| 92 | MP0002249_abnormal_larynx_morphology | 0.70249240 |
| 93 | MP0001664_abnormal_digestion | 0.68062760 |
| 94 | MP0005670_abnormal_white_adipose | 0.67171086 |
| 95 | MP0002060_abnormal_skin_morphology | 0.66904820 |
| 96 | MP0004957_abnormal_blastocyst_morpholog | 0.66713547 |
| 97 | MP0000537_abnormal_urethra_morphology | 0.66550006 |
| 98 | MP0004185_abnormal_adipocyte_glucose | 0.65931380 |
| 99 | MP0000538_abnormal_urinary_bladder | 0.64325316 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.63588517 |
| 101 | MP0000762_abnormal_tongue_morphology | 0.63054122 |
| 102 | MP0009764_decreased_sensitivity_to | 0.62434494 |
| 103 | MP0001873_stomach_inflammation | 0.61859508 |
| 104 | MP0000427_abnormal_hair_cycle | 0.60456112 |
| 105 | MP0005408_hypopigmentation | 0.60104532 |
| 106 | MP0001881_abnormal_mammary_gland | 0.58746150 |
| 107 | MP0008469_abnormal_protein_level | 0.58143484 |
| 108 | MP0000470_abnormal_stomach_morphology | 0.58110553 |
| 109 | MP0001188_hyperpigmentation | 0.57656335 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.57087276 |
| 111 | MP0001191_abnormal_skin_condition | 0.56807651 |
| 112 | MP0003011_delayed_dark_adaptation | 0.56275057 |
| 113 | MP0002111_abnormal_tail_morphology | 0.55773582 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.55071620 |
| 115 | MP0005647_abnormal_sex_gland | 0.54870468 |
| 116 | MP0003718_maternal_effect | 0.53878932 |
| 117 | MP0000467_abnormal_esophagus_morphology | 0.53775312 |
| 118 | MP0008872_abnormal_physiological_respon | 0.52903556 |
| 119 | MP0002078_abnormal_glucose_homeostasis | 0.51835063 |
| 120 | MP0003045_fibrosis | 0.51779542 |
| 121 | MP0000613_abnormal_salivary_gland | 0.51204666 |
| 122 | MP0005395_other_phenotype | 0.51190858 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.50597858 |
| 124 | MP0002928_abnormal_bile_duct | 0.50047444 |
| 125 | MP0003638_abnormal_response/metabolism_ | 0.49363960 |
| 126 | MP0005376_homeostasis/metabolism_phenot | 0.48676317 |
| 127 | MP0009763_increased_sensitivity_to | 0.48436385 |
| 128 | MP0001849_ear_inflammation | 0.47492404 |
| 129 | MP0002132_abnormal_respiratory_system | 0.47469982 |
| 130 | MP0000579_abnormal_nail_morphology | 0.47319215 |
| 131 | MP0002168_other_aberrant_phenotype | 0.45164562 |
| 132 | MP0000383_abnormal_hair_follicle | 0.44573771 |
| 133 | MP0009931_abnormal_skin_appearance | 0.44440144 |
| 134 | MP0005166_decreased_susceptibility_to | 0.42532031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.77179402 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.51019447 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.39663539 |
| 4 | Plantar hyperkeratosis (HP:0007556) | 5.33362916 |
| 5 | Abnormality of nail color (HP:0100643) | 5.22329422 |
| 6 | Xanthomatosis (HP:0000991) | 5.20917659 |
| 7 | Milia (HP:0001056) | 4.88293378 |
| 8 | Deep venous thrombosis (HP:0002625) | 4.86729414 |
| 9 | Palmoplantar hyperkeratosis (HP:0000972) | 4.64177491 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.61236926 |
| 11 | Abnormal hair laboratory examination (HP:0003328) | 4.57144252 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.35093408 |
| 13 | Palmar hyperkeratosis (HP:0010765) | 4.30840987 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.24353385 |
| 15 | Prolonged partial thromboplastin time (HP:0003645) | 4.07675626 |
| 16 | Thick nail (HP:0001805) | 4.03853955 |
| 17 | Hyperglycinuria (HP:0003108) | 3.91759685 |
| 18 | Flat acetabular roof (HP:0003180) | 3.76058169 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.70503629 |
| 20 | Hyperammonemia (HP:0001987) | 3.57263820 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.56521160 |
| 22 | Gout (HP:0001997) | 3.53095903 |
| 23 | Complement deficiency (HP:0004431) | 3.52277542 |
| 24 | Malnutrition (HP:0004395) | 3.50203004 |
| 25 | Hyperglycinemia (HP:0002154) | 3.50045164 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.49323784 |
| 27 | Fat malabsorption (HP:0002630) | 3.45503864 |
| 28 | Nail dystrophy (HP:0008404) | 3.43266534 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 3.38632484 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.38149083 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.38149083 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.36046128 |
| 33 | Ridged nail (HP:0001807) | 3.34514873 |
| 34 | Abnormal blistering of the skin (HP:0008066) | 3.29694098 |
| 35 | Right ventricular cardiomyopathy (HP:0011663) | 3.27910536 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.19332184 |
| 37 | Atrophic scars (HP:0001075) | 3.19194116 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.17588351 |
| 39 | Ketosis (HP:0001946) | 3.17456147 |
| 40 | Abnormal cartilage morphology (HP:0002763) | 3.12438531 |
| 41 | Conjugated hyperbilirubinemia (HP:0002908) | 3.08552245 |
| 42 | Epidermoid cyst (HP:0200040) | 3.05461809 |
| 43 | Posterior subcapsular cataract (HP:0007787) | 2.99395853 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.95909986 |
| 45 | Pterygium (HP:0001059) | 2.91604053 |
| 46 | Hypotrichosis (HP:0001006) | 2.91014883 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.90425134 |
| 48 | Late onset (HP:0003584) | 2.90363406 |
| 49 | Abdominal distention (HP:0003270) | 2.88206505 |
| 50 | Hyperactive renin-angiotensin system (HP:0000841) | 2.86205099 |
| 51 | Sparse eyelashes (HP:0000653) | 2.83461344 |
| 52 | Lip pit (HP:0100267) | 2.82445389 |
| 53 | Joint hemorrhage (HP:0005261) | 2.82435597 |
| 54 | Thin bony cortex (HP:0002753) | 2.82375148 |
| 55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80099579 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.79941182 |
| 57 | Esophageal varix (HP:0002040) | 2.75030602 |
| 58 | Focal segmental glomerulosclerosis (HP:0000097) | 2.75008240 |
| 59 | Hypoplasia of dental enamel (HP:0006297) | 2.70636865 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.69663827 |
| 61 | Cupped ribs (HP:0000887) | 2.69093783 |
| 62 | Increased purine levels (HP:0004368) | 2.63913035 |
| 63 | Hyperuricemia (HP:0002149) | 2.63913035 |
| 64 | Abnormality of complement system (HP:0005339) | 2.62215679 |
| 65 | Popliteal pterygium (HP:0009756) | 2.61473894 |
| 66 | Ketoacidosis (HP:0001993) | 2.61079893 |
| 67 | Abnormality of the salivary glands (HP:0010286) | 2.60322331 |
| 68 | Abnormality of methionine metabolism (HP:0010901) | 2.59353057 |
| 69 | Ileus (HP:0002595) | 2.57140468 |
| 70 | Neonatal short-limb short stature (HP:0008921) | 2.54933637 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52361423 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.51032568 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51032568 |
| 74 | Selective tooth agenesis (HP:0001592) | 2.49194803 |
| 75 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.49065591 |
| 76 | Vascular calcification (HP:0004934) | 2.48778722 |
| 77 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.47826069 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.41668631 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.41668631 |
| 80 | Alkalosis (HP:0001948) | 2.39095302 |
| 81 | Glomerulosclerosis (HP:0000096) | 2.37532668 |
| 82 | Glycosuria (HP:0003076) | 2.36757242 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.36757242 |
| 84 | Trismus (HP:0000211) | 2.34191831 |
| 85 | Fragile nails (HP:0001808) | 2.34077652 |
| 86 | Abnormality of chloride homeostasis (HP:0011422) | 2.33959238 |
| 87 | Vertebral clefting (HP:0008428) | 2.33509140 |
| 88 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.33171711 |
| 89 | Villous atrophy (HP:0011473) | 2.33171711 |
| 90 | Steatorrhea (HP:0002570) | 2.33073300 |
| 91 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.32124982 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 2.31652893 |
| 93 | Erythema (HP:0010783) | 2.30942062 |
| 94 | Metabolic acidosis (HP:0001942) | 2.30303450 |
| 95 | Advanced eruption of teeth (HP:0006288) | 2.30006818 |
| 96 | Curly hair (HP:0002212) | 2.29162145 |
| 97 | Hyperbilirubinemia (HP:0002904) | 2.28655204 |
| 98 | Oral leukoplakia (HP:0002745) | 2.27371671 |
| 99 | Fragile skin (HP:0001030) | 2.26976373 |
| 100 | Widely patent fontanelles and sutures (HP:0004492) | 2.26777539 |
| 101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26228242 |
| 102 | Amelogenesis imperfecta (HP:0000705) | 2.25948487 |
| 103 | Irritability (HP:0000737) | 2.23569881 |
| 104 | Generalized aminoaciduria (HP:0002909) | 2.23167722 |
| 105 | Lethargy (HP:0001254) | 2.22537915 |
| 106 | Proximal tubulopathy (HP:0000114) | 2.21580447 |
| 107 | Cardiovascular calcification (HP:0011915) | 2.17739392 |
| 108 | Hepatocellular carcinoma (HP:0001402) | 2.17705339 |
| 109 | Acanthosis nigricans (HP:0000956) | 2.15502524 |
| 110 | Distal lower limb amyotrophy (HP:0008944) | 2.14568388 |
| 111 | Vacuolated lymphocytes (HP:0001922) | 2.14474210 |
| 112 | Dry hair (HP:0011359) | 2.14326324 |
| 113 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.14235317 |
| 114 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.14218483 |
| 115 | Pancreatitis (HP:0001733) | 2.13241696 |
| 116 | Natal tooth (HP:0000695) | 2.12233486 |
| 117 | Hemorrhage of the eye (HP:0011885) | 2.11624876 |
| 118 | Myocardial infarction (HP:0001658) | 2.11400725 |
| 119 | Pili torti (HP:0003777) | 2.11397925 |
| 120 | Abnormality of the gastric mucosa (HP:0004295) | 2.09376142 |
| 121 | Subcapsular cataract (HP:0000523) | 2.08832188 |
| 122 | Abnormality of permanent molar morphology (HP:0011071) | 2.08313406 |
| 123 | Abnormality of the dental root (HP:0006486) | 2.08313406 |
| 124 | Taurodontia (HP:0000679) | 2.08313406 |
| 125 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.07861017 |
| 126 | Hypoglycemic seizures (HP:0002173) | 2.07693702 |
| 127 | Upper limb amyotrophy (HP:0009129) | 2.05663639 |
| 128 | Distal upper limb amyotrophy (HP:0007149) | 2.05663639 |
| 129 | Decreased circulating renin level (HP:0003351) | 2.04911761 |
| 130 | Axonal loss (HP:0003447) | 2.01846350 |
| 131 | Hyperphosphaturia (HP:0003109) | 2.01201139 |
| 132 | Rickets (HP:0002748) | 2.00948390 |
| 133 | Delayed CNS myelination (HP:0002188) | 1.99846478 |
| 134 | Hyperglycemia (HP:0003074) | 1.98135892 |
| 135 | Ankyloglossia (HP:0010296) | 1.97572539 |
| 136 | Abnormality of serum amino acid levels (HP:0003112) | 1.97340113 |
| 137 | Flat capital femoral epiphysis (HP:0003370) | 1.97297628 |
| 138 | Hyperparathyroidism (HP:0000843) | 1.96685822 |
| 139 | Corneal erosion (HP:0200020) | 1.96513420 |
| 140 | Bronchomalacia (HP:0002780) | 1.96460855 |
| 141 | Ventricular tachycardia (HP:0004756) | 1.94984395 |
| 142 | Dehydration (HP:0001944) | 1.93444032 |
| 143 | Palmoplantar keratoderma (HP:0000982) | 1.93302923 |
| 144 | Woolly hair (HP:0002224) | 1.93225096 |
| 145 | Systemic lupus erythematosus (HP:0002725) | 1.92294706 |
| 146 | Visceral angiomatosis (HP:0100761) | 1.91161956 |
| 147 | Oligodontia (HP:0000677) | 1.90674609 |
| 148 | Abnormality of molar (HP:0011077) | 1.90282458 |
| 149 | Abnormality of molar morphology (HP:0011070) | 1.90282458 |
| 150 | Amniotic constriction ring (HP:0009775) | 1.89722960 |
| 151 | Abnormality of placental membranes (HP:0011409) | 1.89722960 |
| 152 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89406136 |
| 153 | Onycholysis (HP:0001806) | 1.89313960 |
| 154 | Nephrolithiasis (HP:0000787) | 1.89222340 |
| 155 | Sparse scalp hair (HP:0002209) | 1.86955933 |
| 156 | Broad face (HP:0000283) | 1.86900278 |
| 157 | Delayed epiphyseal ossification (HP:0002663) | 1.84735487 |
| 158 | Abnormality of the dental pulp (HP:0006479) | 1.84123701 |
| 159 | Anonychia (HP:0001798) | 1.83942022 |
| 160 | Symptomatic seizures (HP:0011145) | 1.83920901 |
| 161 | Abnormality of the 1st metacarpal (HP:0010009) | 1.83892650 |
| 162 | Alopecia of scalp (HP:0002293) | 1.82932222 |
| 163 | Absent eyelashes (HP:0000561) | 1.82866055 |
| 164 | Neonatal onset (HP:0003623) | 1.81107950 |
| 165 | Spontaneous abortion (HP:0005268) | 1.80899727 |
| 166 | Spastic diplegia (HP:0001264) | 1.80399152 |
| 167 | Neonatal death (HP:0003811) | 1.79047042 |
| 168 | Hyponatremia (HP:0002902) | 1.78247550 |
| 169 | Cervical subluxation (HP:0003308) | 1.75518822 |
| 170 | Septate vagina (HP:0001153) | 1.75137207 |
| 171 | Pustule (HP:0200039) | 1.74423589 |
| 172 | Hyperphosphatemia (HP:0002905) | 1.71996124 |
| 173 | Blepharitis (HP:0000498) | 1.71105522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 9.11694156 |
| 2 | MST1R | 5.53101951 |
| 3 | PIK3CA | 4.28291564 |
| 4 | EPHB2 | 3.61819275 |
| 5 | EPHA2 | 3.08246330 |
| 6 | FRK | 3.02974621 |
| 7 | MAP2K2 | 2.76034678 |
| 8 | MAP3K2 | 2.42014619 |
| 9 | RIPK1 | 2.34596654 |
| 10 | BCKDK | 2.31046764 |
| 11 | MET | 2.16289181 |
| 12 | SMG1 | 2.10780313 |
| 13 | KSR2 | 2.01243697 |
| 14 | ERN1 | 1.99350801 |
| 15 | NME2 | 1.90070232 |
| 16 | SIK1 | 1.80563429 |
| 17 | IRAK3 | 1.79019588 |
| 18 | MST4 | 1.77097103 |
| 19 | FGFR4 | 1.74173335 |
| 20 | PTK6 | 1.57600075 |
| 21 | MAPK15 | 1.49399402 |
| 22 | LMTK2 | 1.43123631 |
| 23 | PTK2 | 1.35568913 |
| 24 | TAOK1 | 1.34584112 |
| 25 | STK24 | 1.32414915 |
| 26 | MAP2K1 | 1.31679392 |
| 27 | STK38L | 1.20673529 |
| 28 | PIK3CG | 1.19498611 |
| 29 | NME1 | 1.17594385 |
| 30 | WNK3 | 1.13686563 |
| 31 | GRK6 | 1.11650431 |
| 32 | INSRR | 1.11349601 |
| 33 | ARAF | 1.06441257 |
| 34 | FER | 1.04162880 |
| 35 | ERBB4 | 1.04049793 |
| 36 | MAP3K3 | 1.03201982 |
| 37 | TESK2 | 0.97290930 |
| 38 | PDGFRA | 0.94838458 |
| 39 | PRKG2 | 0.93018880 |
| 40 | MAP3K1 | 0.92917930 |
| 41 | ACVR1B | 0.92288458 |
| 42 | EEF2K | 0.89939794 |
| 43 | MAP3K14 | 0.88084304 |
| 44 | PBK | 0.86363707 |
| 45 | WNK4 | 0.86010687 |
| 46 | LATS1 | 0.82948873 |
| 47 | EPHB1 | 0.80689607 |
| 48 | NUAK1 | 0.80349604 |
| 49 | PKN2 | 0.80153241 |
| 50 | ERBB2 | 0.76377820 |
| 51 | NTRK1 | 0.72510334 |
| 52 | PIM2 | 0.72093440 |
| 53 | RPS6KB2 | 0.71757266 |
| 54 | LATS2 | 0.68422693 |
| 55 | MAP3K6 | 0.66716932 |
| 56 | MAPK11 | 0.66381570 |
| 57 | EPHA3 | 0.65916895 |
| 58 | CDK12 | 0.63699465 |
| 59 | DDR2 | 0.62279643 |
| 60 | MYLK | 0.59675641 |
| 61 | MAP3K11 | 0.59359435 |
| 62 | MAP3K7 | 0.59356406 |
| 63 | MAP3K8 | 0.58839909 |
| 64 | PRKD2 | 0.58618507 |
| 65 | PRKCI | 0.58265158 |
| 66 | TRIB3 | 0.57798498 |
| 67 | CDC42BPA | 0.55881520 |
| 68 | TESK1 | 0.54701969 |
| 69 | MUSK | 0.51660599 |
| 70 | CAMK2D | 0.50369623 |
| 71 | MAP2K6 | 0.42743790 |
| 72 | PAK4 | 0.39749788 |
| 73 | CSK | 0.39417272 |
| 74 | OXSR1 | 0.38574455 |
| 75 | FLT3 | 0.35915784 |
| 76 | DAPK1 | 0.35715146 |
| 77 | ILK | 0.35563079 |
| 78 | CAMK2G | 0.35351105 |
| 79 | NLK | 0.34759258 |
| 80 | MAP2K3 | 0.33792087 |
| 81 | CDK6 | 0.33380354 |
| 82 | STK10 | 0.33136271 |
| 83 | RPS6KA4 | 0.32523598 |
| 84 | ICK | 0.31274677 |
| 85 | DYRK1B | 0.30606244 |
| 86 | BRAF | 0.30488373 |
| 87 | PRKAA2 | 0.30173138 |
| 88 | JAK2 | 0.29926468 |
| 89 | RPS6KA2 | 0.28225535 |
| 90 | MAP3K9 | 0.27179544 |
| 91 | MARK2 | 0.26740285 |
| 92 | GSK3A | 0.26605536 |
| 93 | KDR | 0.26283032 |
| 94 | MAPKAPK2 | 0.25888638 |
| 95 | RET | 0.25657175 |
| 96 | ABL2 | 0.25469719 |
| 97 | ITK | 0.25096212 |
| 98 | PRPF4B | 0.23793562 |
| 99 | CDK7 | 0.23686072 |
| 100 | DMPK | 0.22986043 |
| 101 | MAP3K10 | 0.22480815 |
| 102 | PDPK1 | 0.22187660 |
| 103 | TBK1 | 0.21107245 |
| 104 | SIK3 | 0.20789569 |
| 105 | IRAK2 | 0.20773626 |
| 106 | MAP3K13 | 0.20398326 |
| 107 | PDK2 | 0.19557351 |
| 108 | CDK9 | 0.18870319 |
| 109 | GRK1 | 0.18624943 |
| 110 | MAPKAPK3 | 0.17857341 |
| 111 | MATK | 0.17756760 |
| 112 | STK3 | 0.16985855 |
| 113 | LRRK2 | 0.16848742 |
| 114 | SCYL2 | 0.16393463 |
| 115 | PRKCA | 0.16257213 |
| 116 | PRKCQ | 0.16048751 |
| 117 | STK38 | 0.15708021 |
| 118 | TYK2 | 0.15652643 |
| 119 | SGK223 | 0.15334771 |
| 120 | SGK494 | 0.15334771 |
| 121 | IRAK1 | 0.14899961 |
| 122 | TLK1 | 0.14714559 |
| 123 | AKT3 | 0.14538112 |
| 124 | PRKAA1 | 0.14331244 |
| 125 | SGK3 | 0.13617467 |
| 126 | PRKACG | 0.13405126 |
| 127 | MELK | 0.13130528 |
| 128 | PRKCZ | 0.12567135 |
| 129 | STK39 | 0.11853292 |
| 130 | MTOR | 0.10838589 |
| 131 | AURKB | 0.09425721 |
| 132 | * SRC | 0.08391391 |
| 133 | CHUK | 0.08387847 |
| 134 | FGFR1 | 0.08232040 |
| 135 | BMX | 0.08049533 |
| 136 | IGF1R | 0.07664690 |
| 137 | MAP3K12 | 0.07596952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.41716686 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26651226 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.22791583 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.67231769 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.55529183 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45131976 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45056285 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.42933489 |
| 9 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.41213032 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.35281933 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.21127340 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19445331 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.18994215 |
| 14 | Bile secretion_Homo sapiens_hsa04976 | 2.13326776 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.12566039 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.11588833 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.08903725 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.07143148 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00255468 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.98178601 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.94448016 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.93217074 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.91873626 |
| 24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82221894 |
| 25 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.79989849 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.77026165 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.73258819 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69289683 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.65163482 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61347072 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58145631 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53419429 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52967692 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.50904222 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49679412 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.46022108 |
| 37 | Sulfur relay system_Homo sapiens_hsa04122 | 1.43515776 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39985412 |
| 39 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37390226 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37182484 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35526821 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.34437299 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25693753 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.20691701 |
| 45 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16927416 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14348336 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11574056 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09392769 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.08494855 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.06845946 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06677441 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.05339035 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02488560 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.99568996 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99160919 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97959666 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96874640 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.95874725 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.94413271 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92225113 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90885322 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.85352315 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78855804 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76956723 |
| 65 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76634746 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74324227 |
| 67 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69271232 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67818218 |
| 69 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67364515 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63523946 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.62032568 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59518025 |
| 73 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56123637 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52642402 |
| 75 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52001219 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51345947 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51180398 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50737054 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47970940 |
| 80 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44870156 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44266234 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43892898 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.39610988 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.36523938 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33156199 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | 0.29736971 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.27937000 |
| 88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27753793 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27627446 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.25655085 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24912215 |
| 92 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24561676 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.24076147 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.23944177 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23795029 |
| 96 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23069709 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.22006685 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.21905248 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21729040 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21168551 |
| 101 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20889133 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.20089113 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19998752 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.18963056 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.17166764 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.16671244 |
| 107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15191502 |
| 108 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.13282728 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.12571635 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.09741482 |
| 111 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.09678862 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.04449815 |
| 113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04161983 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.02923085 |
| 115 | Adherens junction_Homo sapiens_hsa04520 | 0.02127390 |
| 116 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.00313206 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0234141 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0177852 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0052423 |

